Back to search results

Cervical Cancer Screening Through Self-sampling in the Emergency Department

This study is looking at a new way to screen for cervical cancer (cancer of the lower part of the uterus) using self-sampling in the Emergency Department (ED). The goal is to see how many people choose to get screened this way. You may be able to join if you are a woman or transgender/non-binary individual with a cervix, between 30 and 65 years old. We are looking for about 200 participants. The study is currently recruiting, but the exact status is unclear. This research aims to understand if offering self-sampling in the ED can increase the number of people getting screened for HPV (human papillomavirus), which can cause cervical cancer.

Study design
This is a single-arm pilot study, meaning all participants will receive the same intervention. Approximately 200 participants are planned for enrollment.
What's involved
You would perform self-sampling for cervical cancer. Follow-up will occur at 150 days to check on your screening activities and experiences.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for about 150 days after enrollment to determine cervical cancer screening activity and experiences.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07345897

Emergency Department-based Cervical Cancer Screening Through Self-sampling

Recruiting
NAAges 30–65InterventionalScreening
University of Rochester
~200 participants
Updated 2026-05-04 on ClinicalTrials.gov
What's tested:Cervical Cancer Screening

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Uptake of cervical cancer screening from self-sampling in the ED
Measured over In about 150 days of enrollment

Conditions

HPV
HPV Associated Cancers
HPV Cancers
Cervical Cancer Screening
Cervical Cancer (Early Detection)

Explore related trials

Cervical Carcinoma

Where it's being run

1 sites across 1 states
New York1

Who to contact

Research Administrator
[email protected]
585-274-1509
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Cisgender women and transgender/non-binary individuals with a cervix,

Exclusion

Past hysterectomy with cervical removal
Known infection with HIV (as screening recommendations for people with HIV differ from the general population)
Inability to consent (e.g., lacking decisional capacity, intoxicated, or in distress)
Current pregnancy or in the three months after giving birth
Use of vaginal ovules, creams or washes, vaginal contraceptives or condoms within past 3 days
Sexual intercourse or transvaginal ultrasound scans or gynecological examinations within past 2 days

What this trial measures

  • Uptake of cervical cancer screening from self-sampling in the EDIn about 150 days of enrollment

    Number of subjects referred for additional screening who follow through with next steps in the screening process.